196 related articles for article (PubMed ID: 29604917)
1. Prostate Cancer Biomarkers: Current Status.
Hodges KB; Bachert E; Cheng L
Crit Rev Oncog; 2017; 22(5-6):253-269. PubMed ID: 29604917
[TBL] [Abstract][Full Text] [Related]
2. Genomic Predictors of Outcome in Prostate Cancer.
Boström PJ; Bjartell AS; Catto JW; Eggener SE; Lilja H; Loeb S; Schalken J; Schlomm T; Cooperberg MR
Eur Urol; 2015 Dec; 68(6):1033-44. PubMed ID: 25913390
[TBL] [Abstract][Full Text] [Related]
3. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
[TBL] [Abstract][Full Text] [Related]
4. Genomic Markers in Prostate Cancer Decision Making.
Cucchiara V; Cooperberg MR; Dall'Era M; Lin DW; Montorsi F; Schalken JA; Evans CP
Eur Urol; 2018 Apr; 73(4):572-582. PubMed ID: 29129398
[TBL] [Abstract][Full Text] [Related]
5. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
[TBL] [Abstract][Full Text] [Related]
6. New markers in prostate cancer: Genomics.
Fuessel S; Wirth MP
Arch Esp Urol; 2019 Mar; 72(2):116-125. PubMed ID: 30855012
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.
Wei L; Wang J; Lampert E; Schlanger S; DePriest AD; Hu Q; Gomez EC; Murakam M; Glenn ST; Conroy J; Morrison C; Azabdaftari G; Mohler JL; Liu S; Heemers HV
Eur Urol; 2017 Feb; 71(2):183-192. PubMed ID: 27451135
[TBL] [Abstract][Full Text] [Related]
8. Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancer.
Alshalalfa M; Schliekelman M; Shin H; Erho N; Davicioni E
Biol Cell; 2015 Jul; 107(7):232-44. PubMed ID: 25900404
[TBL] [Abstract][Full Text] [Related]
9. Genomes of early onset prostate cancer.
Weischenfeldt J; Korbel JO
Curr Opin Urol; 2017 Sep; 27(5):481-487. PubMed ID: 28661899
[TBL] [Abstract][Full Text] [Related]
10. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
11. Genomic tests to guide prostate cancer management following diagnosis.
Colicchia M; Morlacco A; Cheville JC; Karnes RJ
Expert Rev Mol Diagn; 2017 Apr; 17(4):367-377. PubMed ID: 28277880
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer.
Costa-Pinheiro P; Patel HR; Henrique R; Jerónimo C
Expert Rev Anticancer Ther; 2014 Nov; 14(11):1349-58. PubMed ID: 25148431
[TBL] [Abstract][Full Text] [Related]
13. Genomic and phenotypic heterogeneity in prostate cancer.
Haffner MC; Zwart W; Roudier MP; True LD; Nelson WG; Epstein JI; De Marzo AM; Nelson PS; Yegnasubramanian S
Nat Rev Urol; 2021 Feb; 18(2):79-92. PubMed ID: 33328650
[TBL] [Abstract][Full Text] [Related]
14. Unfavorable Pathology, Tissue Biomarkers and Genomic Tests With Clinical Implications in Prostate Cancer Management.
Nguyen JK; Magi-Galluzzi C
Adv Anat Pathol; 2018 Sep; 25(5):293-303. PubMed ID: 29727322
[TBL] [Abstract][Full Text] [Related]
15. The Genomic and Molecular Pathology of Prostate Cancer: Clinical Implications for Diagnosis, Prognosis, and Therapy.
Faisal FA; Lotan TL
Adv Anat Pathol; 2020 Jan; 27(1):11-19. PubMed ID: 31503032
[TBL] [Abstract][Full Text] [Related]
16. Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.
Van Neste L; Partin AW; Stewart GD; Epstein JI; Harrison DJ; Van Criekinge W
Prostate; 2016 Sep; 76(12):1078-87. PubMed ID: 27121847
[TBL] [Abstract][Full Text] [Related]
17. High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer.
Zhao SG; Jackson WC; Kothari V; Schipper MJ; Erho N; Evans JR; Speers C; Hamstra DA; Niknafs YS; Nguyen PL; Schaeffer EM; Ross AE; Den RB; Klein EA; Jenkins RB; Davicioni E; Feng FY
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):229-36. PubMed ID: 25986914
[TBL] [Abstract][Full Text] [Related]
18. Novel biomarkers and genomic tests in prostate cancer: a critical analysis.
Falzarano SM; Ferro M; Bollito E; Klein EA; Carrieri G; Magi-Galluzzi C
Minerva Urol Nefrol; 2015 Sep; 67(3):211-31. PubMed ID: 26054411
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer invasion and metastasis: insights from mining genomic data.
Hudson BD; Kulp KS; Loots GG
Brief Funct Genomics; 2013 Sep; 12(5):397-410. PubMed ID: 23878130
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer epigenetic biomarkers: next-generation technologies.
Valdés-Mora F; Clark SJ
Oncogene; 2015 Mar; 34(13):1609-18. PubMed ID: 24837368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
